Astrazeneca Pharma India Ltd. Share Price & Stock Analysis

Astrazeneca Pharma India Ltd. (BSE: 506820) is a Bengaluru, Karnataka-based company in the Pharmaceuticals industry. With a market capitalisation of ₹16,078 Cr, it ranks #433 by market cap among the 6,197 Indian listed companies on FinBizNet, and #9 of 63 in Pharmaceuticals. At ₹6,003.00 (as of 16 Nov 2026), the share price is 36.6% below its 52-week high of ₹9,469.50 and 6.4% above its 52-week low of ₹5,640.00. The share price is down 34.3% over one year and down 22.6% over three months.

Key Metrics

Current Price₹6,003.00
Market Cap₹16,078 Cr
BSE Code506820
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Pharmaceuticals
P/E Ratio85.9
Return on Equity22.82%
Return on Assets8.33%
52-Week Range₹5,640.00 – ₹9,469.50
1-Year Price Change-34.3%
3-Month Price Change-22.6%
Beta (1Y)0.28
Dividend Yield0.56%
HeadquartersBengaluru, Karnataka
Websitewww.astrazeneca.in

Latest Quarterly Results — Q2 FY27

Revenue₹729 Cr
Net Profit₹62 Cr
Net Margin8.5%
EPS (Basic)₹24.93
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Astrazeneca Pharma India Ltd. Quarterly Revenue and Profit Trend

Astrazeneca Pharma India Ltd. reported revenue of ₹729 Cr in Q2 FY27, up 30.4% from ₹559 Cr in Q2 FY26 and up 6.8% from ₹683 Cr in Q1 FY27. It posted a net profit of ₹62 Cr for the quarter, against a net profit of ₹54 Cr in Q2 FY26 (up 15.0%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹480 Cr (Q4 FY25) to ₹729 Cr (Q2 FY27). The company was profitable in each of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹729 Cr₹62 Cr8.5%
Q1 FY27₹683 Cr₹38 Cr5.6%
Q4 FY26₹579 Cr₹45 Cr7.8%
Q3 FY26₹612 Cr₹33 Cr5.3%
Q2 FY26₹559 Cr₹54 Cr9.7%
Q1 FY26₹526 Cr₹56 Cr10.6%
Q4 FY25₹480 Cr₹58 Cr12.1%

Standalone figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 75.00% of Astrazeneca Pharma India Ltd.'s shares as of Sept 2026, unchanged from Sept 2025. Delivery averaged 48.8% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Astrazeneca Pharma India Ltd.

AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally. It provides medicines for cardiovascular, renal, metabolic, and immunological conditions; oncology medicines under the TAGRISSO, Lynparza, ENHERTU, IMFINZI, and Zoladex brand names; rare diseases medicines under the Koselugo brand name; and respiratory medicines under the Symbicort and Fasenra brand names. The company also offers medicines for diabetes; and clinical trial services. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.

Products and Services

1. Segment Adjustment-This segment manufactures, markets, and distributes pharmaceutical products; and provides clinical trial services. 2. Healthcare-0 3. Others-This segment provides clinical trial services on pharmaceutical products. 4. Unallocated Assets-0

Business Segments

1. Healthcare-100%

Astrazeneca Pharma India Ltd. vs Peers — Pharmaceuticals

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Abbott India Ltd.₹56,531 Cr36.334.46%₹1,814 Cr-8.1%
Emcure Pharmaceuticals Ltd₹42,344 Cr47.919.57%₹2,820 Cr+73.3%
Ajanta Pharma Limited₹41,474 Cr39.425.39%₹1,794 Cr+27.8%
Piramal Pharma Ltd₹32,600 Crn/m-4.00%₹2,617 Cr+22.8%
RUBICON RESEARCH LIMITED₹28,526 Cr112.319.14%₹576 Cr+162.7%
Caplin Point Laboratories Ltdte₹18,155 Cr28.319.94%₹630 Cr+23.6%
Pfizer Ltd.₹17,811 Cr24.517.16%₹727 Cr-24.2%
Eris Lifesciences Ltd₹17,691 Cr28.318.07%₹892 Cr-17.5%
Astrazeneca Pharma India Ltd.₹16,078 Cr85.922.82%₹729 Cr-34.3%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Astrazeneca Pharma India Ltd.?

Astrazeneca Pharma India Ltd. is trading at ₹6,003.00, with a market capitalisation of ₹16,078 Cr.

Which sector does Astrazeneca Pharma India Ltd. belong to?

Astrazeneca Pharma India Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).

What are the key financial ratios of Astrazeneca Pharma India Ltd.?

Astrazeneca Pharma India Ltd. has a P/E of 85.9 and a return on equity of 22.82%.

What is the stock symbol of Astrazeneca Pharma India Ltd.?

Astrazeneca Pharma India Ltd. is listed on the BSE under the scrip code 506820.

How has Astrazeneca Pharma India Ltd.'s share price moved over the past year?

Astrazeneca Pharma India Ltd.'s share price is down 34.3% over one year and down 22.6% over three months. Its 52-week range is ₹5,640.00 to ₹9,469.50.

What were Astrazeneca Pharma India Ltd.'s latest quarterly results?

In Q2 FY27, Astrazeneca Pharma India Ltd. reported revenue of ₹729 Cr and net profit of ₹62 Cr, with basic EPS of ₹24.93 (standalone, parsed from the company's exchange filing).

How have Astrazeneca Pharma India Ltd.'s revenue and profit changed over the past year?

Astrazeneca Pharma India Ltd. reported revenue of ₹729 Cr in Q2 FY27, up 30.4% from ₹559 Cr in Q2 FY26 and up 6.8% from ₹683 Cr in Q1 FY27.

What is the promoter holding in Astrazeneca Pharma India Ltd.?

Promoters held 75.00% of Astrazeneca Pharma India Ltd.'s shares as of Sept 2026, unchanged from Sept 2025.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.